PRME CIK: 1894562

Prime Medicine, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.1
FY22:
−132
FY23:
−165
FY24:
−123
FY25:
−163
Change from FY21 to FY25
millions USD
FY21:
−73.6
FY22:
−47.1
FY23:
18.7
FY24:
68.5
FY25:
−109
Change from FY21 to FY25
millions USD
FY21:
269
FY22:
181
FY23:
0.66
FY24:
196
FY25:
152
millions USD
FY21:
162
FY22:
2.57
FY23:
−146
FY24:
141
FY25:
−120
(positive)
Change from FY21 to FY25
millions USD
FY21:
−38.2
FY22:
−148
FY23:
−174
FY24:
−130
FY25:
−167

All amounts in millions USD Data source:SEC EDGAR